Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

14 results
Display

False-Positive Axillary Lymph Node on F-18 FDG PET/CT due to Moxibustion Therapy

Jeong SY, Seo JH, Lee SW, Ahn BC, Lee J

  • KMID: 2313130
  • Nucl Med Mol Imaging.
  • 2010 Dec;44(4):307-308.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Multiple Skeletal Muscle Metastases in a Case of Transitional Cell Carcinoma of Bladder Detected by F-18 FDG PET/CT

Kashyap R, Mittal BR, Chakraborty D, Bhattacharya A, Singh B

  • KMID: 2313127
  • Nucl Med Mol Imaging.
  • 2010 Dec;44(4):297-299.
We present a case of poorly differentiated muscle invasive transitional cell carcinoma in a 64-year-old male diagnosed with FDG-avid mass in the urinary bladder wall and multiple skeletal muscles visualised...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Unexpectedly Diagnosed Caroli's Disease on HIDA Scintigraphy in a Patient with Calculous Cholecystitis

Shinto AS, Selvakumar J

  • KMID: 2313129
  • Nucl Med Mol Imaging.
  • 2010 Dec;44(4):304-306.
Caroli's disease, which is a rare condition with congenital dilatation of the intrahepatic bile ducts, is usually diagnosed postoperatively. The clinical suspicion in a patient with gallstones and choledocholithiasis presenting...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hypermetabolic Axillary Mass on 18F FDG PET/CT: Breast Cancer Arising from Accessory Breast Tissue

Park JS, Lee AY, Bae SG, Lee SM

  • KMID: 2313128
  • Nucl Med Mol Imaging.
  • 2010 Dec;44(4):300-303.
Differential diagnosis among several causes of axillary malignant mass is important. The most common cause of palpable malignant axillary mass is metastatic lymphadenopathy. Although carcinoma arising from ectopic breast tissue...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
68Ga-Labeled Radiopharmaceuticals for Positron Emission Tomography

Shetty D, Lee YS, Jeong JM

  • KMID: 2313117
  • Nucl Med Mol Imaging.
  • 2010 Dec;44(4):233-240.
68Ga is a promising emerging radionuclide for positron emission tomography (PET). It is produced using a 68Ge/68Ga-generator, and thus, would enable the cyclotron-independent distribution of PET. However, new 68Ga-labeled radiopharmaceuticals...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Endotracheal Metastasis Seen on FDG PET/CT in a Patient with Previous Colorectal Cancer

Shim HK, Kwon HW, Kim TS, Kim SK

  • KMID: 2313126
  • Nucl Med Mol Imaging.
  • 2010 Dec;44(4):294-296.
Endotracheal/endobronchial metastasis, which is from either primary bronchogenic carcinoma or a tumor of non-pulmonary origin, is a rare but life-threatening condition. Among the different locations in the tracheobronchial tree, the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Ovarian Mass Mimicking Malignancy: A Case Report

Kim YI, Kim SK, Lee JW, Lee SM, Kim TS

  • KMID: 2313125
  • Nucl Med Mol Imaging.
  • 2010 Dec;44(4):290-293.
A 32-year-old female who suffered from abdominal pain underwent 18F-fluorodexoyglucose (FDG) positron emission tomography/computed tomography (PET/CT) for the diagnostic workup of pelvic mass lesions. Cystic mass lesions in the bilateral...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Imaging Atherosclerosis in the Carotid Arteries with F-18-Fluoro-2-deoxy-D-glucose Positron Emission Tomography: Effect of Imaging Time after Injection on Quantitative Measurement

Oh M, Kim JY, Shin KH, Park SH, Ryu JS, Kim JS, Kim HJ, Kang DW, Moon DH

  • KMID: 2313121
  • Nucl Med Mol Imaging.
  • 2010 Dec;44(4):261-266.
PURPOSE: To compare F-18-fluoro-2-deoxy-D-glucose (F-18 FDG) positron emission tomography/computed tomography (PET/CT) imaging at two different circulation times after injection of F-18 FDG in order to measure atherosclerosis in carotid arteries. METHODS:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Estimation of the Release Time from Isolation for Patients with Differentiated Thyroid Cancer Treated with High-dose I-131

Lee JH, Park SG

  • KMID: 2313118
  • Nucl Med Mol Imaging.
  • 2010 Dec;44(4):241-245.
PURPOSE: Patients receiving high-dose I-131 to treat differentiated thyroid cancer are isolated from visitors to limit radiation exposure to reasonable levels. The appropriate isolation time is unclear and has not...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Improved Detection of Lung or Bone Metastases with an I-131 Whole Body Scan on the 7th Day After High-Dose I-131 Therapy in Patients with Thyroid Cancer

Chong A, Song HC, Min JJ, Jeong SY, Ha JM, Kim J, Yoo SU, Oh JR, Bom HS

  • KMID: 2313123
  • Nucl Med Mol Imaging.
  • 2010 Dec;44(4):273-281.
PURPOSE: The purpose of this study is to compare post-therapy third day and seventh day I-131 whole body scans (3DWBS and 7DWBS) in detecting lung or bone metastasis from well-differentiated...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Reproducibility of Gallbladder Ejection Fraction Measured by Fatty Meal Cholescintigraphy

Al-Muqbel , Bani Hani , Elheis MA, Al-Omari M

  • KMID: 2313119
  • Nucl Med Mol Imaging.
  • 2010 Dec;44(4):246-251.
PURPOSE: There are conflicting data in the literature regarding the reproducibility of the gallbladder ejection fraction (GBEF) measured by fatty meal cholescintigraphy (CS). We aimed to test the reproducibility of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Normal Physiologic and Benign Foci with F-18 FDG Avidity on PET/CT in Patients with Breast Cancer

Park SA, Lee KM, Choi U, Kim HS, Kim HW, Song JH

  • KMID: 2313124
  • Nucl Med Mol Imaging.
  • 2010 Dec;44(4):282-289.
PURPOSE: The aim of this study was to evaluate the physiologic and benign F-18 fluorodeoxyglucose (FDG) avid foci in patients with breast cancer. METHODS: On 309 F-18 FDG PET/CT scans of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Behavior and Awareness of Thyroid Cancer Patients in Korea Having Non-Hospitalized Low-Dose Radioiodine Treatment with Regard to Radiation Safety

Kim SG, Paeng JC, Eo JS, Shim HK, Kang KW, Chung JK, Lee MC, Lee DS

  • KMID: 2313122
  • Nucl Med Mol Imaging.
  • 2010 Dec;44(4):267-272.
PURPOSE: With the recent increase in incidence of thyroid cancer, non-hospitalized low-dose (NH-LD) radioiodine treatment (RIT) has also increased rapidly. The radioactivity limit that is allowed to be administered without...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Radiation Safety Issues in Y-90 Microsphere Selective Hepatic Radioembolization Therapy: Possible Radiation Exposure from the Patients

Kim YC, Kim YH, Uhm SH, Seo YS, Park EK, Oh SY, Jeong E, Lee S, Choe JG

  • KMID: 2313120
  • Nucl Med Mol Imaging.
  • 2010 Dec;44(4):252-260.
PURPOSE: The purpose of this study was to estimate the possible external radiation dose to other individuals from patients treated with Y-90 resin microspheres for unresectable hepatocellular carcinoma. METHODS: We designed...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr